Protein modulation in mouse heart under acute and chronic hypoxia

Proteomics

Volumn 11, Issue 21, 2011, Pages 4202-4217

  Viganó, Agnese ^a   Vasso, Michele ^a,b   Caretti, Anna ^a   Bravatá, Valentina ^b,c   Terraneo, Laura ^a   Fania, Chiara ^a   Capitanio, Daniele ^a   Samaja, Michele ^a   Gelfi, Cecilia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^c LATO HSR Giglio   (Italy)

Author keywords

AMPK; Animal proteomics; Apoptosis; Autophagy; Heart; Hypoxia

Indexed keywords

ACETYL COENZYME A; ADENOSYLHOMOCYSTEINASE; ADENYLATE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; CONTRACTILE PROTEIN; HEAT SHOCK PROTEIN; PROTEOME;

ACUTE DISEASE; ANAEROBIC METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; AUTOPHAGY; BIOGENESIS; CHRONIC DISEASE; CONTROLLED STUDY; DOWN REGULATION; ENERGY BALANCE; HEART; HYPOXIA; MASS SPECTROMETRY; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEOMICS; SARCOMERE; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; ANIMAL; ANOXIA; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; IMMUNOBLOTTING; METABOLISM; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

ANIMALIA;

ANIMALS; ANOXIA; APOPTOSIS; CONTRACTILE PROTEINS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOBLOTTING; MICE; MYOCARDIUM; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 84856603825     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000804     Document Type: Article

References (83)

1. Semenza,. L., Nejfelt, M. K., Chi, S. M., Antonarakis, S. E., Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 1991, 88, 5680-5684.
2. Semenza, G. L., HIF-1 and human disease: one highly involved factor. Genes Dev. 2000, 14, 1983-1991.
3. Semenza, G. . Hypoxia-inducible factor 1: master regulator of O2 homeostasis. Curr. Opin. Genet. Dev.. 1998 8, 588-594.
4. Pugh, C. W., Ratcliffe, P. J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 2003, 9, 677-684.
5. Salloum, F. N., Yin, C., Kukreja, R. C. Role of microRNAs in cardiac preconditioning. J. Cardiovasc. Pharmacol. 2010, 56, 581-588.
6. Kim, J. W., Tchernyshyov, I., Semenza, G. L., Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006, 3, 177-185.
7. Fukuda, R., Zhang, H., Kim, J. W., Shimoda, L. et al,. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007, 129, 111-122.
8. Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E. et al,. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 1998, 95, 11715-11720.
9. Shah, A. M., Sauer, H. Transmitting biological information using oxygen: reactive oxygen species as signalling molecules in cardiovascular pathophysiology. Cardiovasc. Res. 2006, 71, 191-194.
10. Guzy, R. D., Schumacker, P. T. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp. Physiol. 2006, 91, 807-819.
11. Acker, T., Fandrey, J., Acker, H. The good, the bad and the ugly in oxygen-sensing: ROS, cytochromes and prolylhydroxylases. Cardiovasc. Res. 2006, 71, 195-207.
12. Cid, C., Garcia-Bonilla, L., Camafeita, E., Burda, J. et al,. Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance. Proteomics 2007, 7, 3207-3218.
13. Kim, N., Lee, Y., Kim, H., Joo, H. et al,. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics 2006, 6, 1237-1249.
14. Gu, J., Wang, Y., Li, J., Wang, J., Jin, T. Proteomic analysis of left ventricular tissues following intermittent myocardial ischemia during coronary collateralization in rabbits. Int. J. Cardiol. 2009, 131, 326-335.
15. Liu, B., Tewari, A. K., Zhang, L., Green-Church, K. B. et al,. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target. Biochim. Biophys. Acta 2009, 1794, 476-485.
16. Jiang, L., Fang, J., Moore, D. S., Gogichaeva, N. V. et al,. Age-associated changes in synaptic lipid raft proteins revealed by two-dimensional fluorescence difference gel electrophoresis. Neurobiol. Aging 2010, 31, 2146-2159.
17. Umstead, T. M., Freeman, W. M., Chinchilli, V. M., Phelps, D. S. Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296, L14-L29.
18. Capitanio, D., Vasso, M., Fania, C., Moriggi, M. et al,. Comparative proteomic profile of rat sciatic nerve and gastrocnemius muscle tissues in ageing by 2-D DIGE. Proteomics 2009, 9, 2004-2020.
19. Vigano, A., Ripamonti, M., De Palma, S., Capitanio, D. et al,. Proteins modulation in human skeletal muscle in the early phase of adaptation to hypobaric hypoxia. Proteomics 2008, 8, 4668-4679.
20. Moriggi, M., Vasso, M., Fania, C., Capitanio, D. et al,. Long term bed rest with and without vibration exercise counter-measures: effects on human muscle protein dysregulation. Proteomics 2010, 10, 3756-3774.
21. Gelfi, C., Vigano, A., Ripamonti, M., Pontoglio, A. et al,. The human muscle proteome in aging. J. Proteome Res. 2006, 5, 1344-1353.
22. Moriggi, M., Cassano, P., Vasso, M., Capitanio, D. et al,. A DIGE approach for the assessment of rat soleus muscle changes during unloading: effect of acetyl-L-carnitine supplementation. Proteomics 2008, 8, 3588-3604.
23. De Palma, S., Ripamonti, M., Viganó, A., Moriggi, M. et al,. Metabolic modulation induced by chronic hypoxia in rats using a comparative proteomic analysis of skeletal muscle tissue. J. Proteome Res. 2007, 6, 1974-1984.
24. Yamaguchi, W., Fujimoto, E., Higuchi, M., Tabata, I. A DIGE proteomic analysis for high-intensity exercise-trained rat skeletal muscle. J. Biochem. 2010, 148, 327-333.
25. Liu, L., Cash, T. P., Jones, R. G., Keith, B. et al,. Hypoxiainduced energy stress regulates mRNA translation and cell growth. Mol. Cell. 2006, 21, 521-531.
26. Hardie, D. G., Hawley, S. A., Scott, J. W,. AMP-activated protein kinase-development of the energy sensor concept. J. Physiol. 2006, 574, 7-15.
27. Arany, Z., He, H., Lin, J., Hoyer, K. et al,. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 2005, 1, 259-271.
28. Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E. et al,. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 2000, 106, 847-856.
29. Adhihetty, P. J., Uguccioni, G., Leick, L., Hidalgo, J. et al,. The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle. Am. J. Physiol. Cell. Physiol. 2009, 297, C217-C225.
30. Whelan, R. S., Kaplinskiy, V., Kitsis, R. N. Cell death in the pathogenesis of heart disease: mechanisms and significance. Annu. Rev. Physiol. 2010, 72, 19-44.
31. Milano, G., Corno, A. F., Lippa, S., Von Segesser, L. K., Samaja, M. Chronic and intermittent hypoxia induce different degrees of myocardial tolerance to hypoxia-induced dysfunction. Exp. Biol. Med. (Maywood) 2002, 227, 389-397.
32. Alban, A., David, S. O., Bjorkesten, L., Andersson, C. et al,. A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003, 3, 36-44.
33. Tonge, R., Shaw, J., Middleton, B., Rowlinson, R. et al,. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 2001, 1, 377-396.
34. Karp, N. A., Kreil, D. P., Lilley, K. S. Determining a significant change in protein expression with DeCyder during a pair-wise comparison using two-dimensional difference gel electrophoresis. Proteomics 2004, 4, 1421-1432.
35. Karp, N. A., Lilley, K. S. Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes. Proteomics 2005, 5, 3105-3115.
36. Benjamini, Y., Hochberg, Y. On the adaptive control of the false discovery rate in multiple testing with independent statistics. J. Edu. Behav. Stat. 2000, 25, 60-83.
37. Marouga, R., David, S., Hawkins, E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 2005, 382, 669-678.
38. Viswanathan, S., Unlu, M., Minden, J. S. Two-dimensional difference gel electrophoresis. Nat. Protoc. 2006, 1, 1351-1358.
39. Taylor, C. F., Paton, N. W., Lilley, K. S., Binz, P. A. et al,. The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 2007, 25, 887-893.
40. John, G. B., Shang, Y., Li, L., Renken, C. et al,. The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol. Biol. Cell. 2005, 16, 1543-1554.
41. Robach, P., Cairo, G., Gelfi, C., Bernuzzi, F. et al,. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle. Blood 2007, 109, 4724-4731.
42. Hausenloy, D. J., Yellon, D. M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc. Res. 2004, 61, 448-460.
43. Csont, T., Gorbe, A., Bereczki, E., Szunyog, A. et al,. Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J. Mol. Cell. Cardiol. 2010, 48, 649-652.
44. Kobayashi, T., Watanabe, Y., Saito, Y., Fujioka, D. et al,. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury. Cardiovasc. Res. 2010, 85, 785-795.
45. Thu, V. T., Kim, H. K., Ha, S. H., Yoo, J. Y. et al,. Glutathione peroxidase 1 protects mitochondria against hypoxia/reoxygenation damage in mouse hearts. Pflugers Arch. 2010, 460, 55-68.
46. Hoshijima, M. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am. J. Physiol. Heart Circ. Physiol. 2006, 290, H1313-H1325.
47. Frey, N., Richardson, J. A., Olson, E. N. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc. Natl. Acad. Sci. USA 2000, 97, 14632-14637.
48. Gong, H., Hatch, V., Ali, L., Lehman, W. et al,. Mini-thin filaments regulated by troponin-tropomyosin. Proc. Natl. Acad. Sci. USA 2005, 102, 656-661.
49. Brunelle, J. K., Bell, E. L., Quesada, N. M., Vercauteren, K. et al,. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005, 1, 409-414.
50. 2 sensing. J. Biol. Chem. 2000, 275, 25130-25138.
51. Mansfield, K. D., Guzy, R. D., Pan, Y., Young, R. M. et al,. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab. 2005, 1, 393-399.
52. Guzy, R. D., Hoyos, B., Robin, E., Chen, H. et al,. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 2005, 1, 401-408.
53. Turrens, J. F., Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 1980, 191, 421-427.
54. Paddenberg, R., Ishaq, B., Goldenberg, A., Faulhammer, P. et al,. Essential role of complex II of the respiratory chain in hypoxia-induced ROS generation in the pulmonary vasculature. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 284, L710-L719.
55. Boveris, A., Cadenas, E., Stoppani, A. O. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem. J. 1976, 156, 435-444.
56. Simon, M. C. Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization. Adv. Exp. Med. Biol. 2006, 588, 165-170.
57. Heather, L. C., Carr, C. A., Stuckey, D. J., Pope, S. et al,. Critical role of complex III in the early metabolic changes following myocardial infarction. Cardiovasc. Res. 2010, 85, 127-136.
58. Hori, O., Ichinoda, F., Tamatani, T., Yamaguchi, A. et al,. Transmission of cell stress from endoplasmic reticulum to mitochondria: enhanced expression of Lon protease. J. Cell. Biol. 2002, 157, 1151-1160.
59. Kahn, B. B., Alquier, T., Carling, D., Hardie, D. G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005, 1, 15-25.
60. Horman, S., Beauloye, C., Vertommen, D., Vanoverschelde, J. L. et al,. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2. J. Biol. Chem. 2003, 278, 41970-41976.
61. Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S. et al,. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol. Cell. Biol. 2005, 25, 9554-9575.
62. Sparks, H. V., Jr., Bardenheuer, H. Regulation of adenosine formation by the heart. Circ. Res. 1986, 58, 193-201.
63. Kobayashi, S., Zimmermann, H., Millhorn, D. E. Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J. Neurochem. 2000, 74, 621-632.
64. Sands, W. A., Palmer, T. M. Adenosine receptors and the control of endothelial cell function in inflammatory disease. Immunol. Lett. 2005, 101, 1-11.
65. Villarreal, F., Zimmermann, S., Makhsudova, L., Montag, A. C. et al,. Modulation of cardiac remodeling by adenosine: in vitro and in vivo effects. Mol. Cell. Biochem. 2003, 251, 17-26.
66. Yoshii, Y., Furukawa, T., Yoshii, H., Mori, T. et al,. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism. Cancer Sci. 2009, 100, 821-827.
67. Lin, J., Handschin, C., Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 2005, 1, 361-370.
68. Lin, J., Wu, P. H., Tarr, P. T., Lindenberg, K. S. et al,. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 2004, 119, 121-135.
69. Rabilloud, T., Heller, M., Gasnier, F., Luche, S. et al,. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 2002, 277, 19396-19401.
70. Cesaratto, L., Vascotto, C., D'Ambrosio, C., Scaloni, A. et al,. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic. Res. 2005, 39, 255-268.
71. Musicco, C., Capelli, V., Pesce, V., Timperio, A. M. et al,. Accumulation of overoxidized Peroxiredoxin III in aged rat liver mitochondria. Biochim. Biophys. Acta 2009, 1787, 890-896.
72. Wagner, E., Luche, S., Penna, L., Chevallet, M. et al,. A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress. Biochem. J. 2002, 366, 777-785.
73. Takagi, H., Matsui, Y., Sadoshima, J. The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart. Antioxid. Redox. Signal. 2007, 9, 1373-1381.
74. Gustafsson, A. B., Gottlieb, R. A. Autophagy in ischemic heart disease. Circ. Res. 2009, 104, 150-158.
75. Zhang, H. M., Cheung, P., Yanagawa, B., McManus, B. M., Yang, D. C. BNips: a group of pro-apoptotic proteins in the Bcl-2 family. Apoptosis 2003, 8, 229-236.
76. Grumati, P., Coletto, L., Sabatelli, P., Cescon, M. et al,. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 2010, 16, 1313-1320.
77. Azuma, T., Koths, K., Flanagan, L., Kwiatkowski, D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J. Biol. Chem. 2000, 275, 3761-3766.
78. Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N. et al,. Gelsolin superfamily proteins: key regulators of cellular functions. Cell. Mol. Life Sci. 2004, 61, 2614-2623.
79. Lin, L., Kim, S. C., Wang, Y., Gupta, S. et al,. HSP60 in heart failure: abnormal distribution and role in cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H2238-H2247.
80. Berberat, P. O., Katori, M., Kaczmarek, E., Anselmo, D. et al,. Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J. 2003, 17, 1724-1726.
81. Pachori, A. S., Smith, A., McDonald, P., Zhang, L. et al,. Heme-oxygenase-1-induced protection against hypoxia/reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J. Mol. Cell. Cardiol. 2007, 43, 580-592.
82. Goven, D., Boutten, A., Lecon-Malas, V., Marchal-Somme, J. et al,. Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha. PLoS One 2010, 5, e10886.
83. Gelfi, C., De Palma, S., Ripamonti, M., Eberini, I. et al,. New aspects of altitude adaptation in Tibetans: a proteomic approach. FASEB J. 2004, 18, 612-614.